Article
In patients with chronic plaque psoriasis treatedwith the human LFA-3/IgG1 fusion protein alefacept (Amevive), early reductionin circulating memory-effector CD45RO+ T-cells may be used to predict ultimateclinical improvement,
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.